Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apricoxib with docetaxel or pemetrexed in advanced NSCLC
NCT00771953Phase 2Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Nov 2008
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of apricoxib in non-small cell lung cancer (NSCLC), sponsored by University of Maryland, Baltimore. Started Nov 2008; status: completed.
02
Drugs
apricoxib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00771953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00771953.